Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05545280 · ClinicalTrials.gov registry record · Phase 4
Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT05545280: Completed Phase 4 study, sponsored by The Cleveland Clinic.
NCT05545280 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05545280, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The investigators propose a randomized trial comparing sugammadex and neostigmine for the reversal of neuromuscular blocks induced by rocuronium or vecuronium in adults having general anesthesia with muscular block for noncardiac surgery.
Primary Outcome
The primary outcome of urinary retention is assessed by post-void bladder volume.
Interventions
- DRUG Sugammadex
- DRUG Neostigmine with glycopyrrolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2024-08-07 |
| Phase | Phase 4 |
What the finished NCT05545280 record still lists
NCT05545280 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Sugammadex is the first listed.
NCT05545280 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05545280 about?
NCT05545280 is a clinical study titled "Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block". The investigators propose a randomized trial comparing sugammadex and neostigmine for the reversal of neuromuscular blocks induced by rocuronium or vecuronium in adults having general anesthesia with muscular block for noncardiac surgery.
What is the current status of trial NCT05545280?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2023-12-01. Estimated completion is 2024-08-07.
What interventions are being tested in trial NCT05545280?
The interventions under investigation include: Sugammadex (DRUG), Neostigmine with glycopyrrolate (DRUG).
Who is sponsoring clinical trial NCT05545280?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05545280's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI